These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

136 related articles for article (PubMed ID: 9371239)

  • 1. Betidamino acid scan of the GnRH antagonist acyline.
    Jiang G; Miller C; Koerber SC; Porter J; Craig AG; Bhattacharjee S; Kraft P; Burris TP; Campen CA; Rivier CL; Rivier JE
    J Med Chem; 1997 Nov; 40(23):3739-48. PubMed ID: 9371239
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Betidamino acids: versatile and constrained scaffolds for drug discovery.
    Rivier JE; Jiang G; Koerber SC; Porter J; Simon L; Craig AG; Hoeger CA
    Proc Natl Acad Sci U S A; 1996 Mar; 93(5):2031-6. PubMed ID: 8700880
    [TBL] [Abstract][Full Text] [Related]  

  • 3. GnRH antagonists: a new generation of long acting analogues incorporating p-ureido-phenylalanines at positions 5 and 6.
    Jiang G; Stalewski J; Galyean R; Dykert J; Schteingart C; Broqua P; Aebi A; Aubert ML; Semple G; Robson P; Akinsanya K; Haigh R; Riviere P; Trojnar J; Junien JL; Rivier JE
    J Med Chem; 2001 Feb; 44(3):453-67. PubMed ID: 11462984
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Gonadotropin-releasing hormone antagonists: novel members of the azaline B family.
    Rivier JE; Jiang G; Porter J; Hoeger CA; Craig AG; Corrigan A; Vale W; Rivier CL
    J Med Chem; 1995 Jul; 38(14):2649-62. PubMed ID: 7629804
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Gonadotropin-releasing hormone antagonists with N omega-triazolylornithine, -lysine, or -p-aminophenylalanine residues at positions 5 and 6.
    Rivier J; Porter J; Hoeger C; Theobald P; Craig AG; Dykert J; Corrigan A; Perrin M; Hook WA; Siraganian RP
    J Med Chem; 1992 Nov; 35(23):4270-8. PubMed ID: 1280300
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Iterative approach to the discovery of novel degarelix analogues: substitutions at positions 3, 7, and 8. Part II.
    Samant MP; Gulyas J; Hong DJ; Croston G; Rivier C; Rivier J
    J Med Chem; 2005 Jul; 48(15):4851-60. PubMed ID: 16033265
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Corticotropin releasing factor (CRF) agonists with reduced amide bonds and Ser7 substitutions.
    Cervini L; Theobald P; Corrigan A; Craig AG; Rivier C; Vale W; Rivier J
    J Med Chem; 1999 Feb; 42(4):761-8. PubMed ID: 10052982
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Novel sst(4)-selective somatostatin (SRIF) agonists. 1. Lead identification using a betide scan.
    Rivier J; Erchegyi J; Hoeger C; Miller C; Low W; Wenger S; Waser B; Schaer JC; Reubi JC
    J Med Chem; 2003 Dec; 46(26):5579-86. PubMed ID: 14667212
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Potent pituitary-gonadal axis suppression and extremely low anaphylactoid activity of a new gonadotropin releasing hormone (GnRH) receptor antagonist "azaline B".
    Campen CA; Lai MT; Kraft P; Kirchner T; Phillips A; Hahn DW; Rivier J
    Biochem Pharmacol; 1995 May; 49(9):1313-21. PubMed ID: 7763313
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Novel gonadotropin-releasing hormone antagonists with substitutions at position 5.
    Samant MP; Hong DJ; Croston G; Rivier C; Rivier J
    Biopolymers; 2005; 80(2-3):386-91. PubMed ID: 15614806
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Constrained corticotropin-releasing factor (CRF) agonists and antagonists with i-(i+3) Glu-Xaa-DXbb-Lys bridges.
    Koerber SC; Gulyas J; Lahrichi SL; Corrigan A; Craig AG; Rivier C; Vale W; Rivier J
    J Med Chem; 1998 Dec; 41(25):5002-11. PubMed ID: 9836618
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Human growth hormone-releasing hormone hGHRH(1-29)-NH2: systematic structure-activity relationship studies.
    Cervini LA; Donaldson CJ; Koerber SC; Vale WW; Rivier JE
    J Med Chem; 1998 Feb; 41(5):717-27. PubMed ID: 9513600
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Development of novel 68Ga- and 18F-labeled GnRH-I analogues with high GnRHR-targeting efficiency.
    Schottelius M; Berger S; Poethko T; Schwaiger M; Wester HJ
    Bioconjug Chem; 2008 Jun; 19(6):1256-68. PubMed ID: 18510351
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Analogues of a potent oxytocin antagonist with truncated C-terminus or shorter amino acid side chain of the basic amino acid at position 8.
    Flouret G; Chaloin O; Slaninová J
    J Pept Sci; 2003 Jun; 9(6):393-401. PubMed ID: 12846485
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Minimal-size, constrained corticotropin-releasing factor agonists with i-(i+3) Glu-Lys and Lys-Glu bridges.
    Rivier J; Lahrichi SL; Gulyas J; Erchegyi J; Koerber SC; Craig AG; Corrigan A; Rivier C; Vale W
    J Med Chem; 1998 Jul; 41(14):2614-20. PubMed ID: 9651165
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Novel gonadotropin-releasing hormone antagonists: peptides incorporating modified N omega-cyanoguanidino moieties.
    Theobald P; Porter J; Rivier C; Corrigan A; Hook W; Siraganian R; Perrin M; Vale W; Rivier J
    J Med Chem; 1991 Aug; 34(8):2395-402. PubMed ID: 1714956
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Synthesis, in vivo and in vitro biological activity of novel azaline B analogs.
    Samant MP; Gulyas J; Hong DJ; Croston G; Rivier C; Rivier J
    Bioorg Med Chem Lett; 2005 Jun; 15(11):2894-7. PubMed ID: 15911275
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Synthesis and biological activity of GnRH antagonists modified at position 3 with 3-(2-methoxy-5-pyridyl)-alanine.
    Samant MP; Miller C; Hong DJ; Koerber SC; Croston G; Rivier CL; Rivier JE
    J Pept Res; 2005 Feb; 65(2):284-91. PubMed ID: 15705170
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Decreased histamine release by luteinizing hormone-releasing hormone antagonists obtained upon translocation of the cationic amino acid from position 8 to position 7.
    Flouret G; Mahan K; Majewski T
    J Med Chem; 1992 Feb; 35(4):636-40. PubMed ID: 1371810
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Synthesis, conformation, biodistribution, and hormone-related in vitro antitumor activity of a gonadotropin-releasing hormone antagonist-branched polypeptide conjugate.
    Mezö G; Mezö I; Pimm MV; Kajtár J; Seprödi J; Teplán I; Kovács M; Vincze B; Pályi I; Idei M; Szekerke M; Hudecz F
    Bioconjug Chem; 1996; 7(6):642-50. PubMed ID: 8950483
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.